Mesothelioma, a rare and incurable cancer of the lining of the lung or belly, challenged the medical community for years. Mesothelioma is diagnosed in 2,000 to 3,000 Americans every year, with as many die from the disease. Although researchers have made progress in recent years, the possibility remains an effective treatment modality for each patient, to identify elusive the fight against of the deadly disease. According to several known mesothelioma specialist, worked on a recent article in clinical lung cancer is however all that change in the next 5 to 10 years if physicians and oncologists adjust treatment for individual patients have the appropriate tools.
DRS. Linda Garland of the Arizona Cancer Center, Raja Flores from Mount Sinai School of medicine in New York and Anne Tsao MD Anderson Cancer Center, all known throughout the world for your mesothelioma expertise agree that "the global burden of mesothelioma increase expected is" over the next decade, especially outside the United States. This statistic underscores the urgent need for continued research in the identification of biomarkers, a disease or health specific condition for mesothelioma biological characteristic associated with make way for personalised treatment.
Personalized cancer treatment specifically optimized for a specific patient the potential for the success of the treatment and patients with the confidence that approach to cancer therapy takes place no "cookie cutter" his physician. Mesothelioma can patients different treatments dramatically and personalised treatment is recommended, frequently used for the multimodal approach.
The use of biomarkers of mesothelioma is a relatively new but promising area of genetic research. For example, the prevalence of a biomarker protein was identified as fabric for longer patients survive MicroRNA-29 c in mesothelioma and forecast improved after surgery, connected according to an important study. These patients may be better candidates for tumor removal surgery if the biomarker is inspected by further research.
In addition, the researchers say it is an opportunity for the development of biomarker allows for the early detection of mesothelioma. A reliable method of screening people who were exposed to asbestos and mesothelioma anticipate would improve improve, fight during cancer treatment options for patients and their quality of life.
Doctors wait still developing a breakthrough drug or a treatment that allows the alignment of mesothelioma can tumors, according to the article. In the next five to ten years say, it is much promising developments towards a better future for mesothelioma patients.
Personalized medicine for mesothelioma
